Cas no 38461-29-9 (2-Nitro-2',4'-dichloro-diphenylether)
2-Nitro-2',4'-dichloro-diphenylether Chemical and Physical Properties
Names and Identifiers
-
- 2,4-Dichloro-1-(2-nitrophenoxy)benzene
- 2',4'-Dichloro-2-nitrodiphenyl ether
- 2,4-Dichlorophenyl o-nitrophenyl ether
- 2-Nitro-2',4'-dichloro-diphenylether
- FT-0645189
- Nicotinicacidhydrazide?
- Z31210042
- SCHEMBL640965
- DTXSID20191782
- NS00030394
- SR-01000423534-1
- AKOS001015561
- UZUWTTGSBGJFLV-UHFFFAOYSA-N
- 1-(2,4-dichlorophenoxy)-2-nitrobenzene
- SR-01000423534
- EINECS 253-952-6
- Oprea1_033477
- 38461-29-9
- 2,4-Dichloro-1-(2-nitro-phenoxy)-benzene
- 2- Nitro-2',4'-dichloro-diphenylether
- DTXCID60114273
-
- Inchi： 1S/C12H7Cl2NO3/c13-8-5-6-11(9(14)7-8)18-12-4-2-1-3-10(12)15(16)17/h1-7H
- InChI Key： UZUWTTGSBGJFLV-UHFFFAOYSA-N
- SMILES： ClC1C=C(C=CC=1OC1C=CC=CC=1[N+](=O)[O-])Cl
Computed Properties
- Exact Mass: 282.98000
- Monoisotopic Mass: 282.98
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 18
- Rotatable Bond Count: 3
- Complexity: 298
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: nothing
- Topological Polar Surface Area: 55A^2
Experimental Properties
- Density: 1.451
- Boiling Point: 355.8°C at 760 mmHg
- Flash Point: 169°C
- Refractive Index: 1.623
- PSA: 55.05000
- LogP: 5.21710
2-Nitro-2',4'-dichloro-diphenylether Customs Data
- HS CODE：2909309090
- Customs Data：
China Customs Code:
2909309090Overview:
2909309090 Other aromatic ethers and their halogenated derivatives\sulfonation\Nitrated derivative(Including nitrosative derivatives).Regulatory conditions:nothing.VAT:17.0%.Tax refund rate:9.0%.MFN tariff:5.5%.general tariff:30.0%
Declaration elements:
Product Name, component content, use to
Summary:
2909309090 other aromatic ethers and their halogenated, sulphonated, nitrated or nitrosated derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0%
2-Nitro-2',4'-dichloro-diphenylether Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A019088412-10g |
2,4-Dichloro-1-(2-nitrophenoxy)benzene |
38461-29-9 | 95% | 10g |
$450.80 | 2023-09-02 | |
| TRC | N233185-50mg |
2-Nitro-2',4'-dichloro-diphenylether |
38461-29-9 | 50mg |
$ 170.00 | 2022-06-03 | ||
| TRC | N233185-100mg |
2-Nitro-2',4'-dichloro-diphenylether |
38461-29-9 | 100mg |
$ 285.00 | 2022-06-03 | ||
| TRC | N233185-250mg |
2-Nitro-2',4'-dichloro-diphenylether |
38461-29-9 | 250mg |
$ 570.00 | 2022-06-03 | ||
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1652028-10g |
2,4-Dichloro-1-(2-nitrophenoxy)benzene |
38461-29-9 | 98% | 10g |
￥6667.00 | 2024-05-15 | |
| Ambeed | A116557-5g |
2,4-Dichloro-1-(2-nitrophenoxy)benzene |
38461-29-9 | 95+% | 5g |
$378.0 | 2024-04-19 | |
| Crysdot LLC | CD12076639-5g |
2,4-Dichloro-1-(2-nitrophenoxy)benzene |
38461-29-9 | 95+% | 5g |
$353 | 2024-07-24 | |
| Crysdot LLC | CD12076639-10g |
2,4-Dichloro-1-(2-nitrophenoxy)benzene |
38461-29-9 | 95+% | 10g |
$564 | 2024-07-24 | |
| abcr | AB627727-500mg |
2,4-Dichloro-1-(2-nitrophenoxy)benzene; . |
38461-29-9 | 500mg |
€146.20 | 2025-04-19 | ||
| abcr | AB627727-1g |
2,4-Dichloro-1-(2-nitrophenoxy)benzene; . |
38461-29-9 | 1g |
€173.20 | 2025-04-19 |
2-Nitro-2',4'-dichloro-diphenylether Related Literature
-
H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
-
Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
-
Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864
-
Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
Additional information on 2-Nitro-2',4'-dichloro-diphenylether
Recent Advances in the Study of 2-Nitro-2',4'-dichloro-diphenylether (CAS: 38461-29-9)
The compound 2-Nitro-2',4'-dichloro-diphenylether (CAS: 38461-29-9) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential applications. This research briefing aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activities, and potential therapeutic uses. The information presented herein is derived from peer-reviewed journals, industry reports, and technical documents published within the last two years.
Recent studies have highlighted the role of 2-Nitro-2',4'-dichloro-diphenylether as a key intermediate in the synthesis of more complex bioactive molecules. Its nitro and chloro functional groups make it a versatile building block for the development of novel pharmaceuticals. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy as a precursor in the synthesis of antimicrobial agents, showing promising activity against drug-resistant bacterial strains. The study utilized advanced spectroscopic techniques, including NMR and mass spectrometry, to confirm the compound's structural integrity and purity.
In addition to its synthetic utility, 2-Nitro-2',4'-dichloro-diphenylether has been investigated for its direct biological effects. A recent in vitro study conducted by researchers at a leading pharmaceutical company revealed that the compound exhibits moderate inhibitory activity against certain enzymes involved in inflammatory pathways. This finding suggests potential applications in the development of anti-inflammatory drugs, although further in vivo studies are required to validate these effects. The study also noted the compound's stability under physiological conditions, which is a critical factor for its potential use in therapeutic formulations.
Another area of interest is the environmental impact and degradation pathways of 2-Nitro-2',4'-dichloro-diphenylether. A 2022 environmental science report examined the compound's persistence in soil and water systems, identifying microbial degradation as a primary mechanism for its breakdown. The study emphasized the need for further research to assess the ecological risks associated with its widespread use in industrial applications. These findings are particularly relevant for regulatory agencies and industries aiming to adopt sustainable practices.
Looking ahead, researchers are exploring the potential of 2-Nitro-2',4'-dichloro-diphenylether in drug delivery systems. Preliminary data from a 2023 nanotechnology study indicated that the compound could be incorporated into polymeric nanoparticles to enhance the targeted delivery of anticancer drugs. This approach leverages the compound's chemical properties to improve drug solubility and bioavailability, addressing key challenges in oncology therapeutics. However, extensive preclinical testing is necessary to evaluate the safety and efficacy of such formulations.
In conclusion, 2-Nitro-2',4'-dichloro-diphenylether (CAS: 38461-29-9) represents a compound of significant interest in multiple research domains, from medicinal chemistry to environmental science. Its dual role as a synthetic intermediate and a bioactive agent underscores its versatility and potential for future applications. Continued research efforts are expected to uncover new insights into its mechanisms of action and therapeutic potential, paving the way for innovative solutions in healthcare and beyond.
38461-29-9 (2-Nitro-2',4'-dichloro-diphenylether) Related Products
- 2363-37-3(Benzene,1-(2-chlorophenoxy)-2,4-dinitro-)
- 37138-82-2(Benzene,1,5-dichloro-2-methoxy-3-nitro-)
- 58457-26-4(Benzene, 1,3,5-trichloro-2-(2-nitrophenoxy)-)
- 32861-85-1(Benzene,2,4-dichloro-1-(3-methoxy-4-nitrophenoxy)-)
- 22544-02-1(2-Nitro-2',4-dichloro-diphenylether)
- 2392-48-5(Benzene,4-chloro-1-(2,4-dichlorophenoxy)-2-nitro-)
- 61147-98-6(Phenol, 2-nitro-5-(2,4,6-trichlorophenoxy)-)
- 54495-63-5( )
- 80866-77-9(2-Chloro-6-nitroanisole)
- 61368-94-3(Benzene,1,3,5-trichloro-2-(2,4-dinitrophenoxy)-)
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
